[ad_1] Otsuka Pharmaceutical (Otsuka), a Tokyo-based health care company, subsidiary of Otsuka Holdings, announced that it has entered into a definitive merger agreement to acquire the developer of 39; Visterra antibody for …
Read More »Otsuka Pharmaceutical of Japan to buy Visterra, supported by Temasek, for $ 430 million
